Month: September 2020

HOUSTON, Sept. 16, 2020 (GLOBE NEWSWIRE) — Targa Resources Corp. (NYSE: TRGP) (“Targa” or the “Company”) announced today that its Sustainability Report for 2019 is now available on the Company’s website at https://www.targaresources.com/sustainability.The report advances Targa’s sustainability disclosures and highlights Targa’s framework of policies, practices and systems in the areas of Safety, Environmental, Social and Governance (ESG).About Targa Resources Corp.Targa Resources Corp. is a leading provider of midstream services and is one of the largest independent midstream infrastructure companies in North America. The Company owns, operates, acquires and develops a diversified portfolio of complementary midstream infrastructure assets. The Company is primarily engaged in the business of: gathering, compressing,...

VIRGINIA CITY, Nev., Sept. 16, 2020 (GLOBE NEWSWIRE) — Comstock Mining Inc. (the “Company” or “Comstock”) (NYSE American: LODE) announced today the election of Mr. Judd B. Merrill, 49, to its Board of Directors. Mr. Merrill is currently the Chief Financial Officer of Aqua Metals, Inc. a clean AquaRefining™ metal recycling technology, since 2018.Mr. Merrill brings extensive public company mining and clean mineral technology industry experience to Comstock. Prior to joining Aqua Metals (NASDAQ: AQMS), Mr. Merrill was the Chief Financial Officer of Comstock, and the Director of Finance & Accounting at Klondex Mines Ltd., a North American based gold and silver mining company that, prior to its acquisition by Hecla Mining Company was a $500 million, publicly traded company listed on the both New York and the Toronto Stock Exchanges. Mr....

– Expansion of Nirogacestat Clinical Program to Include Pediatric Patients Supported by Recent Publication of Nirogacestat Case Series in Four Children/Young Adults with Desmoid Tumors Treated under the SpringWorks Expanded Access Program –– Investigators Reported Clinical Responses in All Four Patients Treated with Nirogacestat, including One Complete Response, Two Partial Responses, and One Stable Disease, with No Grade 3 or 4 Adverse Events Reported – STAMFORD, Conn., Sept. 16, 2020 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced a collaboration with the Children’s Oncology Group (COG) to evaluate nirogacestat, an investigational gamma...

GOFORE PLC COMPANY ANNOUNCEMENT 16 SEPTEMBER 2020 AT 13.30 Composition of Shareholders’ Nomination Board of Gofore Plc  The term of office of the members of Gofore Plc’s Shareholders’ Nomination Board is valid until further notice, until the Annual General Meeting otherwise decides, and ends after the new Nomination Board has been appointed:  Timur Kärki, appointed by Timur Kärki Petteri Venola, appointed by Petteri Venola Mika Varjus, appointed by Mika Varjus Sami Somero, appointed by Gofore Plc’s Board of Directors The Annual General Meeting of Gofore Plc established the Shareholders’ Nomination Board on 29 April 2020. The Nomination Board has four members and three of those members are representatives appointed by the three largest shareholders, and one member is a board member appointed by the company’s Board of Directors from...

GOFORE OYJ YHTIÖTIEDOTE 16.9.2020 KLO 13.30 Gofore Oyj:n osakkeenomistajien nimitystoimikunnan kokoonpano  Gofore Oyj:n osakkeenomistajien nimitystoimikunnan jäsenten toimikausi on voimassa toistaiseksi, kunnes yhtiökokous toisin päättää, ja päättyy uuden nimitystoimikunnan tultua nimetyksi:   Timur Kärki, Timur Kärjen nimeämänä Petteri Venola, Petteri Venolan nimeämänä Mika Varjus, Mika Varjuksen nimeämänä Sami Somero, yhtiön hallituksen nimeämänä  Yhtiökokous perusti 29.4.2020 osakkeenomistajien nimitystoimikunnan, joka koostuu neljästä jäsenestä. Heistä kolme on yhtiön kolmen suurimman osakkeenomistajan nimeämä edustaja ja yksi on yhtiön hallituksen keskuudestaan valitsema hallituksen jäsen. Sen osakkeenomistajan edustaja, jonka osuus yhtiön kaikkien osakkeiden tuottamista äänistä Euroclear Finland Oy:n pitämän yhtiön osakasluettelon...

ORLANDO, Fla., Sept. 16, 2020 (GLOBE NEWSWIRE) — Franchise Group, Inc. (NASDAQ: FRG) (“Franchise Group” or the “Company”) today announced the pricing of its underwritten registered public offering of 1,200,000 shares of 7.50% Series A Cumulative Perpetual Preferred Stock, par value $0.01 per share and liquidation preference of $25.00 per share (the “Preferred Stock”) at an initial public offering price of $25.00 per share, raising gross proceeds of $30 million before deducting underwriting discounts, the structuring fee and other estimated offering expenses.In connection with the offering, the Company has granted the underwriters a 30-day option to purchase up to an additional 180,000 shares of Preferred Stock. The offering is expected to close on or about September 18, 2020, subject to customary closing conditions.The Company’s...

Company Announcement No. 13/2020Copenhagen, 16 September 2020Attachment2013_Monthly update_August_2020_16_09_2020_UK

Selskabsmeddelelse nr. 13/2020København, 16. september 2020Vedhæftet fil2013_Maanedlig_opdatering_august_2020_16_09_20_DK

Press Release, Helsinki, 16 September 2020 at 13.00 (EEST)Nexstim Has Received Two NBS System Upgrade Orders in the United StatesNexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) announces that it has in September received two new NBS System upgrade orders from two large hospitals in the United States.System upgrade means upgrading the hospital’s existing Nexstim NBS system technology to the latest SmartFocus® nTMS features that will replace the older system platform.With these new features the hospitals can continue pre-operative mapping for patients with tumours or other lesions with the latest cutting-edge nTMS technology.Mikko Karvinen, CEO of Nexstim, said: “We want our customers to have the latest technology innovations in their use to help them to diagnose accurately, efficiently and safely their...

TAALERI OYJ:N JOHDON LIIKETOIMET 16.9.2020 KLO 13.00IlmoitusvelvollinenNimi: Lindahl, RobinAsema: ToimitusjohtajaLiikkeeseenlaskija: Taaleri OyjLEI: 743700LSJBDD7TMLAD92Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 743700LSJBDD7TMLAD92_20200916091850_2____________________________________________Liiketoimen päivämäärä: 2020-09-15Kauppapaikka: NASDAQ HELSINKI LTD (XHEL)Instrumenttityyppi: OSAKEISIN: FI4000062195Liiketoimen luonne: HANKINTALiiketoimien yksityiskohtaiset tiedot(1): Volyymi: 3 025 Yksikköhinta: 7 EURLiiketoimien yhdistetyt tiedot(1): Volyymi: 3 025 Keskihinta: 7 EUR Taaleri Oyj ViestintäSophie Jolly, Viestintä- ja sijoittajasuhdejohtaja, puh. 040 828 7317, sophie.jolly@taaleri.com